Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**6-chloro-4-(cyclohexyloxy)-3-propylquinolin–2(1H)–one** is a synthetic small molecule belonging to the hydroquinolone class, characterized by a quinoline core substituted with chloro, cyclohexyloxy, and propyl groups. It has been referenced as an experimental compound and is not known to be approved for any therapeutic use. The precise mechanism of action and clinical indications are not established in public databases. Its structure suggests it may act as a quinolone-based inhibitor, but no specific biological target or pharmacological activity has been confirmed in the literature[1][2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 6-chloro-4-(cyclohexyloxy)-3-propylquinolin-2(1H)-one.